Our new website is coming soon, give it a try now and let us have your feedback. Take me to the Beta



Register
Login:
Share:
Email Facebook Twitter


TSX Lithium explorer International Lithium Corp prepares to drill at Raleigh Lake
Exclusive: Hardman & Co Investor Forum - Severn Trent, Calculus Capital, Volta Finance, Residential


Glaxosmithkline Fundamentals



Fundamental Data for Glaxosmithkline (GSK)


Share Price: 1,595.20Bid: 1,595.20Ask: 1,595.40Change: 0.00 (0.00%)No Movement on Glaxosmithkline
Spread: 0.20Spread as %: 0.01%Open: 1,607.40High: 1,608.00Low: 1,587.20Yesterday’s Close: 1,595.20


UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

Glaxosmithkline Market Data


TIDM GSK
Ticker Code GSK.L
ISIN GB0009252882
Currency GBX
Issue Country GB
Sector Ticker NMX4570
Year End 31-Dec-19
Shares in Issue 4,988m
Market Cap. £78,969m
Market Size 1,500
PE Ratio 21.64
Earnings 73.70p
Dividend 80.00p
Yield 5.02%
# of Trades 3,996
Vol Sold 620,984
Vol Bought 864,980
52 Week High 1,648.80p
52 Week High Date 03-Dec-18
52 Week Low 1,408.80p
52 Week Low Date 06-Dec-18



GSK Fundamentals - IFRS


 £ Millions£ Millions£ Millions£ Millions£ Millions
Income Statement31 Dec '1831 Dec '1731 Dec '1631 Dec '1531 Dec '14
Revenue30,821.0030,186.0027,889.0023,923.0023,006.00
Operating Profit / Loss5,483.004,087.002,598.0010,322.003,597.00
Net Interest(717.00)(669.00)(664.00)(653.00)(659.00)
Pre tax Profit4,800.003,525.001,939.0010,526.002,968.00
Post tax Profit4,046.002,169.001,062.008,372.002,831.00
Profit for the Period4,046.002,169.001,062.008,372.002,831.00
Equity Holders of Parent Company3,623.001,532.00912.008,422.002,756.00
Minority Interests423.00637.00150.00(50.00)75.00
      
Continuing EPS
Earnings per Share (Basic)73.70p31.40p18.80p174.30p57.30p
Earnings per Share (Diluted)72.90p31.00p18.60p172.30p56.70p
Earnings per Share (Adjusted)119.40p111.80p102.40p75.70p95.40p
Continuing and Discontinued EPS
Earnings per Share (Basic)73.70p31.40p18.80p174.30p57.30p
Earnings per Share (Diluted)72.90p31.00p18.60p172.30p56.70p
Earnings per Share (Adjusted)119.40p111.80p102.40p75.70p95.40p
      
Dividend per Share80.00p80.00p80.00p100.00p80.00p
      
 £ Millions£ Millions£ Millions£ Millions£ Millions
Balance Sheet31 Dec '1831 Dec '1731 Dec '1631 Dec '1531 Dec '14
Non-Current Assets     
Intangible Assets22,991.0023,296.0024,741.0021,834.0012,044.00
Property, Plant and Equipment11,058.0010,860.0010,808.009,668.009,052.00
Investments1,558.001,101.001,248.001,462.00340.00
Investment Propertiesn/an/an/an/a1,114.00
Other Financial Assets69.008.00n/an/an/a
Other Non-Current Assets5,463.005,209.005,573.003,895.003,423.00
 41,139.0040,474.0042,370.0036,859.0025,973.00
Current Assets     
Inventories5,476.005,557.005,102.004,716.004,231.00
Trade and Other Receivables6,423.006,000.006,026.005,615.004,600.00
Cash at Bank and in Hand3,874.003,833.004,897.005,830.004,338.00
Current Asset Investments84.0078.0089.0075.0069.00
Other Current Assets1,070.00439.00597.00351.001,440.00
 16,927.0015,907.0016,711.0016,587.0014,678.00
      
Other Assetsn/an/an/an/an/a
Total Assets58,066.0056,381.0059,081.0053,446.0040,651.00
      
Current Liabilities     
Borrowings5,793.002,825.004,129.001,308.002,943.00
Other Current Liabilities16,698.0023,744.0014,872.0012,109.0010,352.00
 22,491.0026,569.0019,001.0013,417.0013,295.00
      
Net Current Assetsn/an/an/an/an/a
      
Non-Current Liabilities     
Borrowings20,271.0014,264.0014,661.0015,324.0015,841.00
Provisions1,847.002,032.002,586.001,942.00545.00
Other Non-Current Liabilities9,785.0010,027.0017,870.0013,885.006,034.00
 31,903.0026,323.0035,117.0031,151.0022,420.00
      
Net Assets3,672.003,489.004,963.008,878.004,936.00
      
Capital and Reserves     
Share Capital1,345.001,343.001,342.001,340.001,339.00
Share Premium Account3,091.003,019.002,954.002,831.002,759.00
Other Reserves2,061.002,047.002,220.002,340.002,239.00
Retained Earnings(2,137.00)(6,477.00)(5,392.00)(1,397.00)(2,074.00)
Shareholders Funds4,360.00(68.00)1,124.005,114.004,263.00
      
Minority Interests / Other Equity(688.00)3,557.003,839.003,764.00673.00
Total Equity3,672.003,489.004,963.008,878.004,936.00
      
 31 Dec '1831 Dec '1731 Dec '1631 Dec '1531 Dec '14
Operating Margin17.79%13.54%9.32%46.67%15.64%
Return on Capital Employed64.21%(611.37%)162.89%198.99%29.68%
Dividend Cover1.491.401.280.951.19
Dividend Yield5.40%6.00%5.10%5.80%5.80%
PE Ratio12.5011.8015.3018.1014.40
PEG1.801.300.40n/an/a
Dividend per Share Growthn/an/an/an/a2.56%
Net Asset Value per Share(387.33p)(397.11p)(406.95p)(268.19p)(147.84p)


Glaxosmithkline Key Personnel


CEOEmma Walmsley
ChairmanMoncef Slaoui
CFOIain Mackay



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Home  |  Contact Us  |  About Us  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy  |  Mobile Site  |  About this website design


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.